CD300A and diffuse large B-cell lymphoma: Two shRNAs (shRNA-1 and shRNA-2) specifically targeting CD300A were chosen and both significantly decreased CD300A expression levels in DLBCL cells at both mRNA and protein levels (Figures 2A and 2B).